News Conference News ESC 2024 AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions Caitlin E. Cox September 12, 2024
News Daily News Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs L.A. McKeown August 15, 2024
News Daily News PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives Michael O'Riordan August 02, 2024
News Conference News SCCT 2024 AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk Todd Neale July 25, 2024
News Conference News SCCT 2024 AI Expected to Augment Workload, Not Put Cardiac Imagers Out of Work Todd Neale July 23, 2024
News Daily News Prior Transradial Cath Shouldn’t Mean Radial Graft a No-go for Surgery Michael O'Riordan July 11, 2024
News Daily News Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear Caitlin E. Cox July 03, 2024
News Daily News ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI Michael O'Riordan July 01, 2024
News Daily News Think You Need a Statin? AHA’s Risk Calculator May Disagree Michael O'Riordan June 28, 2024
News Daily News RECOVER IV Impella Trial Halted in the Wake of DanGer Shock Caitlin E. Cox June 18, 2024
News Daily News Excess ApoB Linked to Increased MI, ASCVD Risk in Adults Michael O'Riordan June 04, 2024
News Industry News CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction May 29, 2024
News Conference News EuroPCR 2024 FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI Caitlin E. Cox May 20, 2024
News Conference News EuroPCR 2024 PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3 Yael L. Maxwell May 17, 2024
News Conference News EuroPCR 2024 ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI Shelley Wood May 16, 2024
News Conference News EuroPCR 2024 ORBITA-2: Angina Phenotype Strongly Predicts PCI Response Caitlin E. Cox May 15, 2024
News Daily News Certain Periprocedural MIs Don’t Matter, New Data Allege Michael O'Riordan May 09, 2024